SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Epigral

BSE: 543332 22 Aug 2025
Commodities
₹ 1841.6
Epigral Limited specializes in Specialty Chemicals within the Commodities sector.

Epigral - Share Price & Details

Market Cap
₹8,169
High /Low
2,408 / 1,502
Stock P/E
18.9
Book Value
₹441.0
Dividend Yield
0.32
ROCE
25.1
ROE
₹22.6
Face Value
10.0
PEG Ratio
1.56
EVEBITDA
₹12.1
Debt
593
CMP / FCF
52.9
Debt to equity
₹0.31
NP Ann
358
High price all time
2,408
Piotroski score
₹8.0
Graham Number
1,001
No. Eq. Shares
4.31
Net CF
₹15.5
Net profit
433
Price to book value
4.29
Interest Coverage
₹9.29
Low price all time
386.0
Industry PE
33.2
Reserves
₹1,861
Free Cash Flow
₹254

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
SOUTHERN GAS LTD.92.625.1085.99161.820.060.03
INDO GULF INDUSTRIES LTD.716.01-1.92713.67-0.200
Epigral Limited6147.91604.16065.437.188,16918.9
Galaxy Surfactants Limited8805.5420.48740.711.86790425.9
GUJARAT NARMADA VALLEY FERTILI17510.0780.016010.05.31783413.9

Peer Comparison Chart


About Epigral

Epigral Limited, with Security Code 543332, is a leading player in the Specialty Chemicals industry, categorized under the Commodities sector, offering Equity instruments.


Latest News

Epigral Limited Releases Q1 FY26 Earnings Call Transcript

(07 Aug 2025)
Epigral Ltd ( ($IN:EPIGRAL) ) just unveiled an announcement. Epigral Limited has released the transcript of its Q1 FY26 earnings conference call,...
Read more →

Epigral Limited Just Recorded A 98% EPS Beat: Here's What Analysts Are Forecasting Next

(06 Aug 2025)
NSEI:EPIGRAL 1 Year Share Price vs Fair Value Explore Epigral's Fair Values from the Community and select yours As you...
Read more →

Epigral reports Q1 FY26 PAT at Rs. Revenue stood at Rs.160 Cr

(06 Aug 2025)
However PAT excluding deferred tax liability benefit stood at Rs. 79 crore as against Rs. 86 crore in Q1FY25. Epigral Limited (Epigral)...
Read more →

Epigral Limited (NSE:EPIGRAL) Might Not Be As Mispriced As It Looks

(30 Jul 2025)
With a price-to-earnings (or "P/E") ratio of 23.6x Epigral Limited ( NSE:EPIGRAL ) may be sending bullish signals at...
Read more →

Epigral Limited (543332) Gets Regulatory Approval - Exceptional financial outcomes

(24 Jul 2025)
Epigral Limited (543332) Gets Regulatory Approval ✌️【Equity Trends】✌️ We do the analysis, you reap the rewards — 200%+ returns made possible...
Read more →

Bullish Pattern Emerging on Epigral Limited (EPIGRAL) - Triple-digit returns

(23 Jul 2025)
Bullish Pattern Emerging on Epigral Limited (EPIGRAL) ✌️【Investor Updates】✌️ Our trading intelligence platform has helped members turn small...
Read more →

Company Updates